Heart drug tested for hidden vascular benefits
NCT ID NCT07190144
Summary
This study looked at whether the medication semaglutide improves blood flow through the heart's arteries in people with and without diabetes. Researchers measured blood flow in 122 patients before they started the drug and again three months later. The goal was to see if this common diabetes and weight-loss medication also helps heart health by improving circulation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medicana International Istanbul Hospital
Istanbul, 34520, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.